PYRAZOLO(1,5A) PYRIMIDINE COMPOUNDS AS ANTIVIRAL AGENTS
摘要
The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.
申请公布号
CA2487211(C)
申请公布日期
2010.09.14
申请号
CA20032487211
申请日期
2003.06.02
申请人
NEOGENESIS PHARMACEUTICALS, INC.
发明人
SHIPPS, GERALD W., JR.;ROSNER, KRISTIN E.;POPOVICI-MULLER, JANETA;DENG, YONGQI;WANG, TONG;CURRAN, PATRICK J.
